Table 3.
Outcome (SPPB score), n | n (%) | Hazard ratio (95% CI) | P |
---|---|---|---|
Overall | |||
HF hospitalization | |||
Severe (0–6), 104 | 23 (22.1) | 3.61 (1.19–10.93) | 0.024 |
Mild (7–9), 123 | 17 (13.8) | 2.59 (0.86–7.75) | 0.090 |
No (10–12), 93 | 4 (4.3) | Reference | |
Death | |||
Severe (0–6), 104 | 4 (3.9) | 1.01 (0.22–4.59) | 0.989 |
Mild (7–9), 123 | 7 (5.7) | 1.32 (0.38–4.63) | 0.668 |
No (10–12), 93 | 4 (4.3) | Reference | |
HF hospitalization or death | |||
Severe (0–6), 104 | 26 (25) | 2.58 (1.06–6.30) | 0.038 |
Mild (7–9), 123 | 21 (17.1) | 1.97 (0.83–4.68) | 0.126 |
No (10–12), 93 | 7 (7.5) | Reference | |
Female participants | |||
HF hospitalization | |||
Severe (0–6), 65 | 17 (26.2) | 8.07 (1.05-62.13) | 0.045 |
Mild limitations (7–9), 53 | 3 (5.7) | 1.54 (0.16–14.81) | 0.710 |
No limitations (10–12), 29 | 1 (3.5) | Reference | |
Death | |||
Severe (0–6), 65 | 2 (3.1) | 0.65 (0.05–8.35) | 0.737 |
Mild (7–9), 53 | 1 (1.9) | 0.45 (0.03–7.45) | 0.580 |
No (10–12), 29 | 1 (3.5) | Reference | |
HF hospitalization or death | |||
Severe (0–6), 65 | 19 (29.2) | 4.39 (0.99–19.43) | 0.052 |
Mild (7–9), 53 | 3 (5.7) | 0.76 (0.13–4.57) | 0.765 |
No (10–12), 29 | 2 (6.9) | Reference | |
Male participants | |||
HF hospitalization | |||
Severe (0–6), 39 | 6 (15.4) | 3.4 (0.84–13.8) | 0.087 |
Mild (7–9), 70 | 14 (20.0) | 4.45 (1.28–15.51) | 0.019 |
No (10–12), 64 | 3 (4.7) | Reference | |
Death | |||
Severe (0–6), 39 | 2 (5.1) | 1.03 (0.17–6.28) | 0.977 |
Mild (7–9), 70 | 6 (8.6) | 1.73 (0.43–6.93) | 0.443 |
No (10–12), 64 | 3 (4.7) | Reference | |
HF hospitalization or death | |||
Severe (0–6), 39 | 7 (18.0) | 2.32 (0.73–7.41) | 0.157 |
Mild (7–9), 70 | 18 (25.7) | 3.41 (1.26–9.19) | 0.016 |
No (10–12), 64 | 5 (7.8) | Reference |
Overall hazard ratios were adjusted by age, sex, and New York Heart Association class. Hazard ratios for female and male participants were adjusted by age. “Severe,” “Mild,” and “No” indicate level of limitations.
CI, confidence interval; HF, heart failure.